what percent of americans are on glp 1 The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs percentage of us population on

Whilst these medications do not selectively 'burn' belly fat through direct mechanisms, clinical evidence demonstrates they promote significant overall weight loss, including reductions in visceral adipose tissuethe metabolically harmful fat surrounding internal organs

Sharkovska, Y

doi: 10.1034/j.1399-5618.2002.01180.xCrossRefGoogle ScholarPubMed Pettegrew, J

It acts as a downstream effector of HIF-1

Long-term use of GLP-1 receptor agonists is generally considered safe

However, it is important to recognise that the absence of spotting in the official side effect profile does not mean that patients taking Wegovy never experience menstrual changes